Clinical trial
Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine…
NCT00035555 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00035555 |
|---|---|
| Title | Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney |
| Official title | Phase II/III, Open-Label, Randomized, Controlled, Multiple-Dose Study of Efficacy and Safety of BMS-224818 (Belatacept) as Part of a Quadruple Drug Regimen in First Renal Transplant Recipients |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft Rejection, Kidney Transplantation, Renal Transplantation |
| Intervention type | Drug |
| Interventions | Belatacept, Cyclosporine, Mycophenolate mofetil (MMF), Corticosteroids |
| Enrollment | 230 |
| Start date | Mar 1, 2001 |
| Primary completion | Jan 1, 2004 |
| Completion | Jul 1, 2012 |
| First posted | May 6, 2002 |
| Last update posted | Jan 13, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: